Healthcare
March 22, 2018 / 12:28 PM / a year ago

BRIEF-SSY Group ‍Obtains China FDA Approvals For Drug Production For Hemofiltration Replacement Fluid

1 Min Read

March 22 (Reuters) - SSY Group Ltd:

* ‍OBTAINED APPROVALS FOR DRUG PRODUCTION AND REGISTRATION FOR HEMOFILTRATION REPLACEMENT FLUID FROM CHINA FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below